These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27762143)

  • 1. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
    Yu J; Wang ZJ; Chen LH; Dong WZ
    Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
    Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M
    Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
    Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
    Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F
    Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
    Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
    Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients.
    Bui Huu H; Ha Thuc N; Thi Le HP; Thi Thanh TD; Luong Bac A; Tiribelli C; Pontisso P; Gallotta A; Paneghetti L; Fassina G
    Scand J Clin Lab Invest; 2018 May; 78(3):204-210. PubMed ID: 29381084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
    Montagnana M; Danese E; Lippi G
    Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.
    Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L
    Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
    Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
    J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
    Hussein MM; Ibrahim AA; Abdella HM; Montasser IF; Hassan MI
    Indian J Cancer; 2008; 45(4):167-72. PubMed ID: 19112206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis.
    Zhang J; Shao C; Zhou Q; Zhu Y; Zhu J; Tu C
    Mol Clin Oncol; 2015 Sep; 3(5):1165-1171. PubMed ID: 26623071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
    BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
    Jia X; Liu J; Gao Y; Huang Y; Du Z
    Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC.
    Giannelli G; Marinosci F; Trerotoli P; Volpe A; Quaranta M; Dentico P; Antonaci S
    Int J Cancer; 2005 Nov; 117(3):506-9. PubMed ID: 15906357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.
    Trerotoli P; Fransvea E; Angelotti U; Antonaci G; Lupo L; Mazzocca A; Mangia A; Antonaci S; Giannelli G
    Mol Cancer; 2009 May; 8():29. PubMed ID: 19473531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: a systematic review and meta-analysis.
    Liu XF; Hu ZD; Liu XC; Cao Y; Ding CM; Hu CJ
    Clin Biochem; 2014 Feb; 47(3):196-200. PubMed ID: 24362268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.
    Pontisso P; Quarta S; Caberlotto C; Beneduce L; Marino M; Bernardinello E; Tono N; Fassina G; Cavalletto L; Gatta A; Chemello L
    Int J Cancer; 2006 Aug; 119(4):735-40. PubMed ID: 16550605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.
    Biasiolo A; Tono N; Ruvoletto M; Quarta S; Turato C; Villano G; Beneduce L; Fassina G; Merkel C; Gatta A; Pontisso P
    PLoS One; 2012; 7(7):e40658. PubMed ID: 22808225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.